LifeVantage announces results of third-party cell study of health weight stack
LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...
Nasdaq4d
LifeVantage Corporation Unveils Bold Vision for 2025 at Annual Global Kickoff Event
Results from a third-party study revealed significant synergistic benefits of the MindBody GLP-1 System™ combined with Protandim® Nrf2 Synergizer®, indicating improved organ health ...
Hosted on MSN3d
Craig-Hallum Initiates Coverage of LifeVantage (LFVN) with Buy Recommendation
Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...
manilatimes5d
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
Key findings from the study highlight how the products complement and enhance each other's individual benefits: ...
Frontiers6d
Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction
As a crucial regulator of redox balance, nuclear factor erythroid 2-related factor 2 (Nrf2) governs the transcription of downstream antioxidant enzymes (Huang et al., 2022; Shen et al., 2019). Under ...